| Identification of a novel HLA-DRB1 allele, DRB1*09:20, by sequence-based typing in an unrelated bone marrow donor. | |
| | |
MedLine Citation:
|
PMID: 23330724 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The novel allele HLA-DRB1*09:20 differs from HLA-DRB1*09:01:02 by one nucleotide substitution at codon 9 (AAG->CAG) and differs from HLA-DRB1*09:07 by one nucleotide substitution at codon 13 (TAT->TTT). |
| | |
Authors:
|
G A Hommel-Berrey; K D House; K A Backfish; T S Arnoff; A L Lobashevsky |
Related Documents
:
|
21337664 - Mechanisms of digit formation: human malformation syndromes tell the story. 11765764 - Owning genetic information and gene enhancement techniques: why privacy and property ri... 21145464 - Functional overlap and regulatory links shape genetic interactions between signaling pa... 15297504 - Amplified fragment length polymorphism reveals genomic variability among mycobacterium ... 20465584 - The effects of selection, drift and genetic variation on life-history trait divergence ... 646734 - Dominantly inherited low-frequency hearing loss. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Tissue antigens Volume: 81 ISSN: 1399-0039 ISO Abbreviation: Tissue Antigens Publication Date: 2013 Feb |
Date Detail:
|
Created Date: 2013-01-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0331072 Medline TA: Tissue Antigens Country: England |
Other Details:
|
Languages: eng Pagination: 125-6 Citation Subset: IM |
Copyright Information:
|
© 2013 John Wiley & Sons A/S. |
Affiliation:
|
Department of Medicine, Histocompatibility Laboratory, Indiana University, Indianapolis, IN, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Identification of a novel HLA-A allele, A*24:128 in a Chinese individual.
Next Document: Dose accuracy of a durable insulin pen with memory function, before and after simulated lifetime use...